<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43432">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01767025</url>
  </required_header>
  <id_info>
    <org_study_id>2012/550</org_study_id>
    <nct_id>NCT01767025</nct_id>
  </id_info>
  <brief_title>The Influence of Oxytocin on Automatic Imitation Behaviour in Healthy Adults</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Foundation Flanders</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Ghent</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <authority>Belgium: Federal Agency for Medicinal Products and Health Products</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the influence of oxytocin on automatic imitation behaviour is investigated.
      Healthy adults will be administered with either oxytocin or a placebo, and will perform an
      imitation-inhibition task (as a measure of automatic imitation behaviour). To determine the
      specificity of the oxytocin effect, an unrelated cognitive task (Stroop task) will also be
      presented.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>To evaluate the automatic imitation behaviour 45 minutes after drug administration</measure>
    <time_frame>120 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Since the effects of oxytocin are only visible after 45 minutes, participants will have to wait 45 minutes before starting the experimental tasks. In the meantime, they will be given an unrelated cognitive-emotional filler task which will last Â± 30 minutes. Afterwards, they will perform two experimental tasks: an imitation-inhibition task and a cognitive control task (Stroop task).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxytocin 24 IU (3 puffs) per nostril</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sea water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sea water 3 puffs per nostril</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <arm_group_label>Oxytocin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sea water</intervention_name>
    <arm_group_label>Sea water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  non-smoker

        Exclusion Criteria:

          -  no pacemaker, deep brain stimulation electrodes or other stimulation devices

          -  normal neurological history (no brain operations, migraine, epilepsy, alcoholism

          -  no epilepsy in family

          -  no chronic disease(s) that require constant medication (asthma, hypertension,
             diabetes)

          -  no medication 24h prior to experiment

          -  no alcohol or caffeine 2h prior to experiment

          -  no sleep deprivation 24h prior to experiment
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy T'Sjoen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ghent University, Faculty of Endrocrinology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ghent University, Faculty of Psychology and Educational Sciences</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 16, 2013</lastchanged_date>
  <firstreceived_date>January 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Influence</keyword>
  <keyword>oxytocin</keyword>
  <keyword>automatic imitation</keyword>
  <keyword>behaviour</keyword>
  <keyword>volunteers</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
